Yazar "Önder, Nur İpek" için listeleme
-
Antimicrobial and anticancer effects of some 2-(substitutedsulfanyl)-N-(5-methyl-isoxazol-3-yl)acetamide derivatives
Özkay, Yusuf; Seller, Zerrin; Önder, Nur İpek; Tunalı, Yağmur; Karaca Gencer, Hülya; Işıkdağ, İlhan; Uçucu, Ümit (Springer Birkhauser, 2013)In the present study, some isoxazole-(benz)azole derivatives (3a-3j) were synthesized by considering antimicrobial and anticancer potencies of azole compounds. Chemical structures of obtained compounds (3a-3j) were confirmed ... -
Apoptotic effects of epsilon-viniferin in combination with cis-platin in C6 cells
Özdemir, Filiz; Apaydın, Elif; Önder, Nur İpek; Şen, Mesut; Ayrim, Aysun; Öğünç Keçeci, Yüksel; Seller, Zerrin (Springer, 2018)Glioblastoma (GBM) is one of the most common and lethal forms of primary brain tumors in human adults. Treatment options are limited, and in most cases ineffective. Natural products are sources of novel compounds endowed ... -
Bazı sentetik bileşiklerin anti-kanser özelliklerinin belirlenmesi
Önder, Nur İpek (Anadolu Üniversitesi, 2013)Günümüzde çeşitli kanser türlerinde yoğun olarak kullanılan antrakinon grubu ilaçlara farklı yan zincirlerin eklenmesiyle, terapötik etkilerinin artacağı, oluşturulan yeni antrakinon türevlerinin kanser hücrelerinde direnç ... -
Synthesis and Evaluation of New Dithiocarbamic Acid 6,11-Dioxo-6,11-dihydro-1H-anthra[1,2-d]-imidazol-2-yl Methyl Esters
Önder, Nur İpek; Seller, Zerrin; Özkay, Yusuf (Wiley-V C H Verlag GMBH, 2015)A novel series of dithiocarbamic acid 6,11-dioxo-6,11-dihydro-1H-anthra[1,2-d]imidazol-2-yl methyl esters were synthesized and their cytotoxic and apoptotic activities were evaluated on HeLa cells. Some of these compounds ... -
Towards Novel Anti-tumor Strategies for Hepatic Cancer: epsilon-Viniferin in Combination with Vincristine Displays Pharmacodynamic Synergy at Lower Doses in HepG2 Cells
Özdemir, Filiz; Akalın Çiftçi, Gülsen; Sen, Mesut; Önder, Nur İpek; İşcan, Arzu; Kutlu, Hatice Mehtap; Seller, Zerrin (Mary Ann Liebert, Inc, 2014)Hepatocellular carcinoma is the fifth most common cancer and the third leading cause of cancer-related deaths worldwide. The efficacy of novel combination treatments are increasingly evaluated with use of integrative biology ...
